{"filing": {"accession": "0001493152-26-048567", "cik": "0002078148", "ticker": "ZOAR", "company_name": "Zoar Ltd", "form_type": "424B3", "filing_type": "424B3", "filing_date": "2026-10-26", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/2078148/000149315226048567/0001493152-26-048567-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/2078148/000149315226048567/0001493152-26-048567-index.htm", "period_of_report": null}, "html_url": "/api/filings/000149315226048567/stream", "exhibits": [], "sections": [], "tables": [{"table_index": 0, "table_type": "text", "caption": null, "header_text": "PROXY\n STATEMENT FOR THE SPECIAL MEETINGOF STOCKHOLDERS OFIMPACT BIOMEDICAL INC.PROSPECTUS\n OF ZOAR LIMITED"}, {"table_index": 1, "table_type": "exhibit_index", "caption": null, "header_text": "1.The\n Business Combination Proposal \u2014 to adopt the merger and share exchange agreement, dated June 21, 2025, by and among\n Zoar Limited (f.k.a Dr Ashleys Limited), a Cayman Islands exempted company l"}, {"table_index": 2, "table_type": "text", "caption": null, "header_text": "(a)Merger Sub shall be merged with and into Impact with Impact being the surviving entity (the \u201cMerger\u201d);"}, {"table_index": 3, "table_type": "text", "caption": null, "header_text": "\u25cfthe\n requirement that a majority of the PubCo Board consist of \u201cindependent directors\u201d as defined under the Company Guide\n of the NYSE Amex;"}, {"table_index": 5, "table_type": "exhibit_index", "caption": null, "header_text": "(1)\u201cFOR\u201d\n the adoption of the Business Combination Proposal;"}, {"table_index": 7, "table_type": "text", "caption": null, "header_text": "Name:Frank\n D. Heuszel"}, {"table_index": 8, "table_type": "text", "caption": null, "header_text": "/s/\n Frank D. Heuszel"}, {"table_index": 11, "table_type": "text", "caption": null, "header_text": "(a)Merger\n Sub shall be merged with and into Impact with Impact being the surviving entity (the \u201cMerger\u201d);"}, {"table_index": 12, "table_type": "exhibit_index", "caption": null, "header_text": "2.The Corporate Document Proposal \u2014\n to approve the amended and restated memorandum and articles of association of PubCo(as the surviving company in the Business Combination)\nupon completion of the Bu"}, {"table_index": 16, "table_type": "text", "caption": null, "header_text": "Name:Frank D. Heuszel"}, {"table_index": 19, "table_type": "text", "caption": null, "header_text": "Name:Frank D. Heuszel"}, {"table_index": 21, "table_type": "financial", "caption": null, "header_text": "ABOUT THIS PROXY STATEMENT/PROSPECTUS1"}, {"table_index": 23, "table_type": "text", "caption": null, "header_text": "\u25cfthe\n inability to complete the Business Combination due to the failure to obtain Impact\u2019s stockholder approval;"}, {"table_index": 25, "table_type": "financial", "caption": null, "header_text": "\u25cfthe risk that the proposed Business Combination disrupts current plans\n and operations of Zoar or Impact as a result of the announcement and consummation of the Business Combination;"}, {"table_index": 33, "table_type": "text", "caption": null, "header_text": "\u25cfby\n voting over the Internet using the website indicated on the enclosed proxy card;"}, {"table_index": 35, "table_type": "exhibit_index", "caption": null, "header_text": "1.The\n Business Combination Proposal \u2014 to adopt the merger and share exchange agreement, dated June 21, 2026, as amended, restated,\n supplemented or otherwise modified from time to time, by and among "}, {"table_index": 38, "table_type": "text", "caption": null, "header_text": "\u25cfby\n re-voting at a subsequent time by Internet or by telephone following the instructions on the enclosed proxy card;"}, {"table_index": 40, "table_type": "text", "caption": null, "header_text": "\u25cfFor\n Impact Stockholders of record: Please call Frank D. Heuszel, the Chief Executive Officer of Impact, at (281) 415-6576."}, {"table_index": 42, "table_type": "text", "caption": null, "header_text": "(a)Merger\n Sub shall be merged with and into Impact with Impact being the surviving entity;"}, {"table_index": 44, "table_type": "text", "caption": null, "header_text": "(a)by\n mutual written consent of Impact, PubCo, the Zoar Shareholder, and Zoar;"}, {"table_index": 46, "table_type": "text", "caption": null, "header_text": "\u25cfthe\n PubCo Shares shall have been approved for listing on the NYSE Amex, subject to official notice of issuance;"}, {"table_index": 48, "table_type": "text", "caption": null, "header_text": "Name:Frank\n D. Heuszel"}, {"table_index": 51, "table_type": "text", "caption": null, "header_text": "(a)Merger\n Sub shall be merged with and into Impact with Impact being the surviving entity;"}, {"table_index": 54, "table_type": "exhibit_index", "caption": null, "header_text": "1.The\n Business Combination Proposal \u2014 to adopt the merger and share exchange agreement, dated June 21, 2025, by and among\n Zoar Limited (f.k.a Dr Ashleys Limited), a Cayman Islands exempted company l"}, {"table_index": 57, "table_type": "text", "caption": null, "header_text": "\u25cfPubCo\n shall issue to Frank D. Heuszel, the Chief Executive Officer of Impact a total of 22,000 PubCo Shares, or the Impact Compensation\n Shares, at the closing of the Business Combination.;"}, {"table_index": 59, "table_type": "text", "caption": null, "header_text": "HighLow"}, {"table_index": 61, "table_type": "financial", "caption": null, "header_text": "\u25cfThe\n consummation of the Business Combination is subject to the closing conditions contained in the Merger and Share Exchange Agreement\n and could be delayed or may never occur."}, {"table_index": 63, "table_type": "financial", "caption": null, "header_text": "\u25cfTheBusiness Combination may not qualify as a non-taxable transaction for U.S. federal income tax purposes."}, {"table_index": 64, "table_type": "text", "caption": null, "header_text": "\u25cfThe\n NYSE Reverse Split may not increase the PubCo Share price over the long term."}, {"table_index": 65, "table_type": "financial", "caption": null, "header_text": "\u25cfWe\n have experienced difficulties in satisfying payment obligations to trade credit service providers,\n which may indicate liquidity constraints and could result in material disruption to our busines"}, {"table_index": 66, "table_type": "financial", "caption": null, "header_text": "\u25cfIf\n we cease to qualify as a foreign private issuer, we would be required to comply fully with\n the reporting requirements of the Exchange Act applicable to U.S. domestic issuers, and we\n would incur"}, {"table_index": 68, "table_type": "text", "caption": null, "header_text": "\u25cfAlthough\n we and our subsidiary are not based in mainland China and we have no operations in mainland\n China, the PRC government may intervene or influence our current and future operations in\n Hong "}, {"table_index": 69, "table_type": "text", "caption": null, "header_text": "\u25cfUpon\n completion of the Business Combination, Impact Stockholders will become stockholders\n of PubCo, and the market price for the PubCo Shares may be affected by factors different\n from those that h"}, {"table_index": 71, "table_type": "financial", "caption": null, "header_text": "June\n 30, 2026(unaudited)December 31, 2025"}, {"table_index": 73, "table_type": "financial", "caption": null, "header_text": "For\n the Three Months EndedJune\n 30,For\n the Six Months EndedJune\n 30,"}, {"table_index": 75, "table_type": "financial", "caption": null, "header_text": "Common StockPreferred StockAdditional Paid-inAccumulatedTotal ImpactNon- controlling Interest in"}, {"table_index": 77, "table_type": "financial", "caption": null, "header_text": "20262025"}, {"table_index": 79, "table_type": "financial", "caption": null, "header_text": "For\n the Year Ended December 31,"}, {"table_index": 81, "table_type": "financial", "caption": null, "header_text": "For the Year EndedDecember\n 31,"}, {"table_index": 83, "table_type": "financial", "caption": null, "header_text": "As of March 31,"}, {"table_index": 84, "table_type": "financial", "caption": null, "header_text": "Years ended March 31,"}, {"table_index": 86, "table_type": "text", "caption": null, "header_text": "\u25cfThe\n unaudited pro forma condensed consolidated balance sheet as of March 31, 2026 was prepared from the unaudited, historical\n balance sheet of Impact as of December 31, 2025 and the audited, histor"}, {"table_index": 88, "table_type": "financial", "caption": null, "header_text": "HistoricalTransaction AccountingPro Forma Balance"}, {"table_index": 90, "table_type": "financial", "caption": null, "header_text": "Historical"}, {"table_index": 93, "table_type": "financial", "caption": null, "header_text": "\u25cfits\n employees may experience uncertainty about their future roles, which might adversely affect Zoar ability to retain and hire\n key personnel and other employees;"}, {"table_index": 96, "table_type": "financial", "caption": null, "header_text": "\u25cfImpact\n may experience negative reactions from the financial markets, including negative impacts on Impact\u2019s stock price (including\n to the extent that the current market price reflects a market assu"}, {"table_index": 100, "table_type": "text", "caption": null, "header_text": "\u25cfdemand\n significantly in excess of forecast demand, which may lead to supply shortages;"}, {"table_index": 102, "table_type": "financial", "caption": null, "header_text": "\u25cfthe timing,\n progress, and results of our launch of new products;"}, {"table_index": 104, "table_type": "text", "caption": null, "header_text": "\u25cfdemand\n for new capital resources."}, {"table_index": 105, "table_type": "text", "caption": null, "header_text": "\u25cfwe\n may never generate the necessary data or results required to obtain regulatory approval and\n achieve product sales in our target markets;"}, {"table_index": 107, "table_type": "text", "caption": null, "header_text": "\u25cfdifficulty\n establishing and managing international operations and the increased costs and risks associated\n with operation, infrastructure and logistics and compliance costs associated with location"}, {"table_index": 108, "table_type": "text", "caption": null, "header_text": "\u25cffluctuations\n in our targeted markets and/or other global economies, including economic downturns or recessions\n and the strength and rate of any general economic recoveries;"}, {"table_index": 111, "table_type": "financial", "caption": null, "header_text": "\u25cfinjury\nto our reputation;"}, {"table_index": 128, "table_type": "text", "caption": null, "header_text": "\u25cfactual\n or anticipated fluctuations in PubCo\u2019s results of operations;"}, {"table_index": 130, "table_type": "financial", "caption": null, "header_text": "\u25cfPubCo\n intends to pay any dividends from its operating surplus, less amounts it retains to fund its expansion, for debt repayment and for\n other corporate purposes, as determined by PubCo\u2019s managemen"}, {"table_index": 135, "table_type": "text", "caption": null, "header_text": "\u25cfthe\n audited consolidated financial statements of Zoar Labs Limited as of and for the years ended March 31, 2026\n and 2025 prepared in accordance with U.S. GAAP and in its presentation and functional"}, {"table_index": 137, "table_type": "exhibit_index", "caption": null, "header_text": "1.The\n Business Combination Proposal \u2014 to adopt the merger and share exchange agreement, dated June 21, 2025, by and among\n Zoar Limited (f.k.a Dr Ashleys Limited), a Cayman Islands exempted company l"}, {"table_index": 138, "table_type": "exhibit_index", "caption": null, "header_text": "\u25cfProposal\n 1:\u201cFOR\u201d the Business Combination Proposal;"}, {"table_index": 140, "table_type": "exhibit_index", "caption": null, "header_text": "ProposalRequired\n VoteEffects\n of Certain Actions"}, {"table_index": 142, "table_type": "text", "caption": null, "header_text": "\u25cfBy\n Internet: By following the instructions provided on your proxy card."}, {"table_index": 144, "table_type": "text", "caption": null, "header_text": "\u25cfby\n sending a signed written notice of revocation to Impact\u2019s corporate secretary, provided such notice is received no later than\n the close of business on November 12, 2026;"}, {"table_index": 147, "table_type": "text", "caption": null, "header_text": "Name:Frank\n D. Heuszel"}, {"table_index": 151, "table_type": "text", "caption": null, "header_text": "NameAgePosition(s)\n with the CompanyDate\n First Elected or Appointed"}, {"table_index": 154, "table_type": "text", "caption": null, "header_text": "NAMEPOSITION"}, {"table_index": 158, "table_type": "text", "caption": null, "header_text": "\u25cfoversee\n management in the performance of its responsibility for the integrity of the Company\u2019s accounting and financial reporting and\n its systems of internal controls,"}, {"table_index": 160, "table_type": "text", "caption": null, "header_text": "\u25cfthe\n adequacy and form of compensation of the Board;"}, {"table_index": 161, "table_type": "text", "caption": null, "header_text": "\u25cfdeveloping\n criteria for membership on the board of directors and committees;"}, {"table_index": 163, "table_type": "text", "caption": null, "header_text": "NameFees Earned or Paid in CashStock Awards (1)All Other Compensation (2)Total"}, {"table_index": 166, "table_type": "text", "caption": null, "header_text": "Name and principal positionYearSalaryBonusStock Awards (1)Option AwardsNon-Equity Incentive Plan CompensationNonqualified Deferred Compensation\n EarningsAll Other Compensation (2)Total"}, {"table_index": 167, "table_type": "text", "caption": null, "header_text": "(1)Represents\n the total grant date fair value of stock options awards computed in accordance with FASB ASC 718. Our policy and assumptions made\n in the valuation of share-based payments are contained"}, {"table_index": 169, "table_type": "text", "caption": null, "header_text": "\u25cfeach\n of our named executive officers;"}, {"table_index": 170, "table_type": "text", "caption": null, "header_text": "Percentage of"}, {"table_index": 174, "table_type": "text", "caption": null, "header_text": "(a)Merger\n Sub shall be merged with and into Impact with Impact being the surviving entity;"}, {"table_index": 180, "table_type": "financial", "caption": null, "header_text": "\u25cfThe potential risks of\n an investment in this industry, including a review of risk factors included in other public transactions, many of which are applicable\n to Zoar. (With such risk factors being "}, {"table_index": 192, "table_type": "financial", "caption": null, "header_text": "\u25cbConsidered\n its assessment of general economic, market and financial conditions as well as its experience\n in connection with similar transaction, and business and securities valuations generally;"}, {"table_index": 195, "table_type": "financial", "caption": null, "header_text": "Exchange/TTMTTMFY+1FY+1"}, {"table_index": 196, "table_type": "financial", "caption": null, "header_text": "FY+1FY+1"}, {"table_index": 197, "table_type": "financial", "caption": null, "header_text": "FY+1FY+1"}, {"table_index": 199, "table_type": "financial", "caption": null, "header_text": "\u25cfTax\n rate of 16.50% based on the Hong Kong corporate tax rate"}, {"table_index": 201, "table_type": "text", "caption": null, "header_text": "\u25cfZoaris led by an experienced senior management team with decades of proven experience in the Pharmaceutical industry and a track record\n of building large successful companies."}, {"table_index": 202, "table_type": "text", "caption": null, "header_text": "\u25cfZoarcurrent plans for continuing to expand its business to confirm the likelihood that it would possess sufficient financial resources\n and the access to future growth capital to allow management to "}, {"table_index": 205, "table_type": "financial", "caption": null, "header_text": "ProjectedProjected"}, {"table_index": 206, "table_type": "financial", "caption": null, "header_text": "(1)Revenue\n was estimated based on the expected sales of products by product category and region for the respective period indicated using Zoar\n management\u2019s judgment. See \u201cProjected sales by product "}, {"table_index": 207, "table_type": "financial", "caption": null, "header_text": "\u25cfProjection\n based on organic sales and profitability growth from the existing customer base;"}, {"table_index": 208, "table_type": "financial", "caption": null, "header_text": "Revenue by Product Category($s in 000s)QuantityProjectedQuantityProjected"}, {"table_index": 211, "table_type": "financial", "caption": null, "header_text": "Geographical revenue($s in 000s)"}, {"table_index": 213, "table_type": "text", "caption": null, "header_text": "Year end 2026US$5,150,000"}, {"table_index": 214, "table_type": "financial", "caption": null, "header_text": "\u25cfR&D\n Expenses: it is assumed that the R&D expenses comprises of formulation and testing of the drugs with respect to their\n quality, gradation, crystallization and synthesis. In addition, the employe"}, {"table_index": 216, "table_type": "text", "caption": null, "header_text": "\u25cfPubCo shall issue to Frank D. Heuszel, the Chief\n Executive Officer of Impact a total of 22,000 PubCo Shares (the \u201cImpact Compensation Shares\u201d) at the closing of the Business\n Combination. For the av"}, {"table_index": 218, "table_type": "text", "caption": null, "header_text": "\u25cfthe requirement that a majority of the PubCo Board\n consist of \u201cindependent directors\u201d as defined under the rules of the NYSE Amex;"}, {"table_index": 221, "table_type": "text", "caption": null, "header_text": "(a)Merger Sub shall be merged with and into Impact\n with Impact being the surviving entity;"}, {"table_index": 223, "table_type": "exhibit_index", "caption": null, "header_text": "\u25cforganization\n and standing;"}, {"table_index": 224, "table_type": "financial", "caption": null, "header_text": "\u25cffinancial\n statements;"}, {"table_index": 225, "table_type": "text", "caption": null, "header_text": "\u25cfagreements,\n contracts and commitments;"}, {"table_index": 227, "table_type": "text", "caption": null, "header_text": "\u25cfinsurance;"}, {"table_index": 253, "table_type": "text", "caption": null, "header_text": "\u25cfprivacy\n and data security;"}, {"table_index": 288, "table_type": "financial", "caption": null, "header_text": "HistoricalTransaction AccountingPro Forma Balance"}, {"table_index": 290, "table_type": "financial", "caption": null, "header_text": "Historical"}, {"table_index": 292, "table_type": "text", "caption": null, "header_text": "\u25cfAn\n issuance of 8,890,000 PubCo Ordinary Shares at $6 per share (or $53.3 million in aggregate)\n in exchange for all Impact Shares after giving effect to the reverse split of Impact shares\n (the \u201cNYS"}, {"table_index": 297, "table_type": "text", "caption": null, "header_text": "Number of shares before the reverse stock splitReverse stock split rateShares issued to directors & officers prior to ClosingNumber of shares after the reverse stock split"}, {"table_index": 298, "table_type": "financial", "caption": null, "header_text": "(b)Represents\n the conversion of the related party note payable, as discussed in note 4(a) above, of $1.3\n million to 228,000 shares of PubCo common stock, par value $0.001 per share pursuant to the\n "}, {"table_index": 300, "table_type": "text", "caption": null, "header_text": "PubCo Ordinary Shares issued as Impact Merger Consideration at Closing8,640,000"}, {"table_index": 301, "table_type": "financial", "caption": null, "header_text": "Cash and cash equivalents$20"}, {"table_index": 302, "table_type": "financial", "caption": null, "header_text": "(e)Represents\n the elimination of Impact\u2019s historical equity and historical value of the assets and liabilities."}, {"table_index": 304, "table_type": "text", "caption": null, "header_text": "(A)Derived\n from the audited consolidated statement of operations of Zoar Labs and Subsidiaries\n for the year ended March 31, 2026."}, {"table_index": 305, "table_type": "financial", "caption": null, "header_text": "(a)Reflects\n amortization expense recorded on the acquired intangible assets based on their estimated\n remaining useful lives ranging from 12.5 to 15.5 years."}, {"table_index": 309, "table_type": "text", "caption": null, "header_text": "\u25cfSubject\n to satisfaction or waiver of terms and conditions of the Merger and Share Exchange Agreement, at the Merger Effective Time (as defined\n in the Merger and Share Exchange Agreement), the Merge"}, {"table_index": 310, "table_type": "text", "caption": null, "header_text": "\u25cfReceipt\n of all required regulatory and stockholder approvals;"}, {"table_index": 313, "table_type": "financial", "caption": null, "header_text": "For\n the periodfrom\n June 6, 2025(inception)\n toMarch\n 31, 2026"}, {"table_index": 315, "table_type": "financial", "caption": null, "header_text": "For\n the period fromJune\n 6, 2025(inception)\n toMarch\n 31, 2026"}, {"table_index": 318, "table_type": "text", "caption": null, "header_text": "For the period fromJune 6, 2025(inception) toMarch 31, 2026"}, {"table_index": 320, "table_type": "text", "caption": null, "header_text": "\u25cfImpact BioLife Science, Inc.;"}, {"table_index": 327, "table_type": "text", "caption": null, "header_text": "\u25cfLineBacker: Multi-faceted therapeutic platform for metabolic, neurologic, cancer, and infectious diseases."}, {"table_index": 332, "table_type": "text", "caption": null, "header_text": "\u25cfthe\n continuing listing requirements of the New York Stock Exchange American;"}, {"table_index": 337, "table_type": "financial", "caption": null, "header_text": "ThreemonthsendedJune\n 30, 2026ThreemonthsendedJune\n 30, 2025%ChangeSixmonthsendedJune\n 30, 2026SixmonthsendedJune\n 30, 2025%Change"}, {"table_index": 338, "table_type": "financial", "caption": null, "header_text": "ThreemonthsendedJune\n 30, 2026ThreemonthsendedJune\n 30, 2025%ChangeSix\n monthsendedJune\n 30, 2026Six\n monthsendedJune\n 30, 2025%Change"}, {"table_index": 340, "table_type": "financial", "caption": null, "header_text": "ThreemonthsendedJune\n 30, 2026ThreemonthsendedJune\n 30, 2025%ChangeSixmonthsendedJune\n 30, 2026SixmonthsendedJune\n 30, 2025%Change"}, {"table_index": 342, "table_type": "text", "caption": null, "header_text": "ThreemonthsendedJune\n 30, 2026ThreemonthsendedJune\n 30, 2025%ChangeSixmonthsendedJune\n 30, 2026SixmonthsendedJune\n 30, 2025%Change"}, {"table_index": 344, "table_type": "financial", "caption": null, "header_text": "Year endedDecember 31, 2025Year endedDecember 31, 2024% Change"}, {"table_index": 345, "table_type": "financial", "caption": null, "header_text": "Year endedDecember 31, 2025Year endedDecember 31, 2024% Change"}, {"table_index": 347, "table_type": "financial", "caption": null, "header_text": "Year\n endedDecember\n 31, 2025Year\n endedDecember\n 31,2024% Change"}, {"table_index": 348, "table_type": "text", "caption": null, "header_text": "Year\n endedDecember\n 31, 2025Year\n endedDecember\n 31, 2024% Change"}, {"table_index": 352, "table_type": "text", "caption": null, "header_text": "\u25cfGlobal\n Reach and Market Penetration: We have established a strong global emerging markets presence, distributing our products across\n more than 35 countries. This extensive market reach allows us to"}, {"table_index": 366, "table_type": "text", "caption": null, "header_text": "\u25cfManufacture\n \u2013 Apex shall manufacture specified products exclusively for us at its Telangana plant\n on a contract basis in such quantities specified by us. We are responsible for providing\n the relev"}, {"table_index": 374, "table_type": "text", "caption": null, "header_text": "TypeAddressSizeTerm of Lease"}, {"table_index": 378, "table_type": "text", "caption": null, "header_text": "\u25cfSubject\n to satisfaction or waiver of terms and conditions of the Merger and Share Exchange Agreement, at the Merger Effective Time (as\n defined in the Merger and Share Exchange Agreement), the Merge"}, {"table_index": 380, "table_type": "text", "caption": null, "header_text": "\u25cfReceipt\n of all required regulatory and stockholder approvals;"}, {"table_index": 382, "table_type": "text", "caption": null, "header_text": "\u25cfContinuing\n successful execution of sales and marketing strategy including growing business with existing customers and developing commercial\n relationships with new customers globally;"}, {"table_index": 384, "table_type": "financial", "caption": null, "header_text": "\u25cfStrategic\n planning, budgeting, and resource allocation; and"}, {"table_index": 385, "table_type": "financial", "caption": null, "header_text": "Year Ended March 31,"}, {"table_index": 387, "table_type": "financial", "caption": null, "header_text": "\u25cfCustomer\n Ordering Patterns: Large-volume orders and long-term supply agreements can result in quarter-to-quarter variability in revenue recognition.\n Periods with significant bulk shipments may lead"}, {"table_index": 389, "table_type": "text", "caption": null, "header_text": "\u25cfCompensation\n and benefits for scientists and technical personnel;"}, {"table_index": 390, "table_type": "financial", "caption": null, "header_text": "\u25cfEmployee-related\n compensation and benefits for management, sales, marketing, human resources, and administrative personnel;"}, {"table_index": 392, "table_type": "financial", "caption": null, "header_text": "Years ended March 31,Change"}, {"table_index": 393, "table_type": "text", "caption": null, "header_text": "Years ended March 31,Change"}, {"table_index": 396, "table_type": "text", "caption": null, "header_text": "\u25cfThe\n pace and structure of financing activities related to growth initiatives;"}, {"table_index": 399, "table_type": "text", "caption": null, "header_text": "Years Ended March 31,"}, {"table_index": 401, "table_type": "financial", "caption": null, "header_text": "\u25cfAccounts\n payable: $87.9 million"}, {"table_index": 403, "table_type": "text", "caption": null, "header_text": "\u25cfCustomer-specific\n developments that may affect future payment behavior;"}, {"table_index": 405, "table_type": "financial", "caption": null, "header_text": "(i)Staffing\n for financial, accounting and external reporting areas, including segregation of duties\u037e"}, {"table_index": 408, "table_type": "text", "caption": null, "header_text": "(i)Our\n lack of sufficient financial reporting and accounting personnel with appropriate knowledge of U.S. GAAP and SEC reporting requirements\n to properly address U.S GAAP technical accounting issues"}, {"table_index": 409, "table_type": "text", "caption": null, "header_text": "(i)Hiring\n more qualified staff to fill up the key roles in the operations;"}, {"table_index": 411, "table_type": "text", "caption": null, "header_text": "\u25cfBy\n Drug Type:The API market is divided into two main categories based on drug type: innovative APIs and generic APIs. Innovative\n APIs are those used in the production of new, patented drugs, while "}, {"table_index": 413, "table_type": "text", "caption": null, "header_text": "\u25cfAging\n Population: The global population is aging, leading to an increase in the prevalence of chronic diseases and a higher demand\n for medications. This demographic shift is expected to drive the d"}, {"table_index": 416, "table_type": "text", "caption": null, "header_text": "\u25cfHigh\n Manufacturing Costs:The production of APIs involves sophisticated processes and high-quality standards, which can result in\n substantial manufacturing costs. These costs can be a barrier, espec"}, {"table_index": 418, "table_type": "text", "caption": null, "header_text": "\u25cfMajor\n players dominate the industry. The Intermediates market is driven by companies expanding their manufacturing capabilities and\n enhancing product portfolios through strategic initiatives. Marke"}, {"table_index": 420, "table_type": "text", "caption": null, "header_text": "\u25cfOncology:Orphan drugs targeting oncology will benefit from the rising incidences of rare cancers and advancements in genomic profiling\n and precision medicine. Regulatory incentives like market exclu"}, {"table_index": 422, "table_type": "text", "caption": null, "header_text": "\u25cfHigh\n Return on Investment: Major pharmaceutical companies are grappling with challenges such as a limited patient population, patent\n expirations of branded drugs, stringent regulations, a dwindling"}, {"table_index": 423, "table_type": "text", "caption": null, "header_text": "\u25cfHigh\n Cost Associated with Drug Development:Drug development often faces significant early-stage challenges, especially in clinical\n trials. The smaller patient pool for rare diseases means lower exp"}, {"table_index": 425, "table_type": "text", "caption": null, "header_text": "\u25cfService\n Type: API manufacturing; finished dosage form (FDF) development and manufacturing; secondary packaging."}, {"table_index": 426, "table_type": "text", "caption": null, "header_text": "\u25cfIncreasing\n Complexity of Drug Development: The development of new drugs, especially biologics and personalized medicines, is becoming more\n complex. CDMOs offer the necessary expertise and resources"}, {"table_index": 438, "table_type": "text", "caption": null, "header_text": "\u25cfPrinciple\n 1 \u2014 purpose and manner of collection of personal data;"}, {"table_index": 440, "table_type": "text", "caption": null, "header_text": "\u25cfthe\n right to be informed by a data user whether the data user holds personal data of which the individual is the data subject;"}, {"table_index": 441, "table_type": "text", "caption": null, "header_text": "(a)identical\n to the trademark in relation to goods or services which are identical to those for which it is registered;"}, {"table_index": 446, "table_type": "text", "caption": null, "header_text": "(a)providing\n and maintaining plant and work systems that are, so far as reasonably practicable, safe and without risks to health;"}, {"table_index": 448, "table_type": "text", "caption": null, "header_text": "NameAgePosition"}, {"table_index": 451, "table_type": "text", "caption": null, "header_text": "\u25cfestablishing\n clear hiring policies for employees or former employees of the independent auditors;"}, {"table_index": 453, "table_type": "text", "caption": null, "header_text": "\u25cfreviewing\n and evaluating PubCo\u2019s executive compensation and benefits policies generally;"}, {"table_index": 454, "table_type": "text", "caption": null, "header_text": "\u25cfrecommending\n nominees to PubCo\u2019s board of directors for election or re-election to PubCo\u2019s board of directors, or for appointment\n to fill any vacancy or newly created directorships on PubCo\u2019s board"}, {"table_index": 456, "table_type": "text", "caption": null, "header_text": "\u25cfour\n board of directors is not required to be comprised of a majority of independent directors."}, {"table_index": 458, "table_type": "text", "caption": null, "header_text": "\u25cfthe\n rules under the Exchange Act requiring the filing of quarterly reports on Form 10-Q or current reports on Form 8-K with the SEC;"}, {"table_index": 467, "table_type": "text", "caption": null, "header_text": "\u25cfthe\n instrument of transfer is lodged with us, accompanied by the certificate for the Ordinary Shares to which it relates and such other\n evidence as our board of directors may reasonably require to "}, {"table_index": 469, "table_type": "text", "caption": null, "header_text": "\u25cfincrease\n our share capital by such sum as the resolution shall prescribe and with such rights, priorities and privileges annexed thereto,\n as we in general meeting may determine;"}, {"table_index": 471, "table_type": "text", "caption": null, "header_text": "NevadaCayman\n Islands"}, {"table_index": 473, "table_type": "text", "caption": null, "header_text": "NevadaCayman\n Islands"}, {"table_index": 475, "table_type": "text", "caption": null, "header_text": "NevadaCayman\n Islands"}, {"table_index": 476, "table_type": "text", "caption": null, "header_text": "NevadaCayman\n Islands"}, {"table_index": 478, "table_type": "text", "caption": null, "header_text": "NevadaCayman\n Islands"}, {"table_index": 479, "table_type": "text", "caption": null, "header_text": "NevadaCayman\n Islands"}, {"table_index": 480, "table_type": "financial", "caption": null, "header_text": "NevadaCayman\n Islands"}, {"table_index": 482, "table_type": "text", "caption": null, "header_text": "NevadaCayman\n Islands"}, {"table_index": 483, "table_type": "text", "caption": null, "header_text": "NevadaCayman\n Islands"}, {"table_index": 485, "table_type": "text", "caption": null, "header_text": "(in thousands of U.S. dollars)As ofMarch 31,As ofMarch 31,"}, {"table_index": 487, "table_type": "text", "caption": null, "header_text": "\u25cfeach\n of our named executive officers;"}, {"table_index": 488, "table_type": "text", "caption": null, "header_text": "NameNumber of Shares Beneficially OwnedPercentage of Outstanding Share\n Beneficially Owned"}, {"table_index": 489, "table_type": "text", "caption": null, "header_text": "*Less\n than 1%"}, {"table_index": 491, "table_type": "text", "caption": null, "header_text": "Beneficial OwnerTotal Number ofPubCo SharesBeneficially Owned (#)Percent ofOutstandingPubCo Shares (%)"}, {"table_index": 498, "table_type": "text", "caption": null, "header_text": "HighLow"}, {"table_index": 501, "table_type": "text", "caption": null, "header_text": "\u25cfpolitical\n and economic stability;"}, {"table_index": 502, "table_type": "text", "caption": null, "header_text": "\u25cfthe\n Cayman Islands has a less developed body of securities laws as compared to the United States and these securities laws provide significantly\n less protection to investors; and"}, {"table_index": 503, "table_type": "text", "caption": null, "header_text": "\u25cfrecognize\n or enforce judgments of United States courts obtained against us or our directors or officers predicated upon the civil liability\n provisions of the securities laws of the United States or"}, {"table_index": 506, "table_type": "exhibit_index", "caption": null, "header_text": "\u25cfQuarterly\n report onForm 10-Qfor the quarter ended June 30, 2026, filed on August 7, 2026."}, {"table_index": 508, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 510, "table_type": "financial", "caption": null, "header_text": "Page"}, {"table_index": 511, "table_type": "financial", "caption": null, "header_text": "ConsolidatedFinancial Statements for the years ended March 31, 2026 and 2025"}, {"table_index": 512, "table_type": "financial", "caption": null, "header_text": "Page"}, {"table_index": 513, "table_type": "financial", "caption": null, "header_text": "Page"}, {"table_index": 514, "table_type": "financial", "caption": null, "header_text": "Page"}, {"table_index": 517, "table_type": "financial", "caption": null, "header_text": "As of March 31,"}, {"table_index": 519, "table_type": "financial", "caption": null, "header_text": "For the period fromJune 6, 2025 (inception) toMarch 31, 2026"}, {"table_index": 521, "table_type": "text", "caption": null, "header_text": "ShareAmountcapitaldeficitdeficit"}, {"table_index": 523, "table_type": "financial", "caption": null, "header_text": "For the period fromJune 6, 2025 (inception) toMarch 31, 2026,"}, {"table_index": 540, "table_type": "text", "caption": null, "header_text": "(in\n thousands of U.S. dollars, except share amounts and per share data)For the period fromJune 6, 2025 (inception) toMarch 31, 2026"}, {"table_index": 543, "table_type": "financial", "caption": null, "header_text": "Table of ContentsPAGE(S)"}, {"table_index": 546, "table_type": "financial", "caption": null, "header_text": "As of March 31,"}, {"table_index": 548, "table_type": "financial", "caption": null, "header_text": "Years ended March 31,"}, {"table_index": 550, "table_type": "financial", "caption": null, "header_text": "Ordinary Shares*"}, {"table_index": 552, "table_type": "financial", "caption": null, "header_text": "Years Ended March 31,"}, {"table_index": 554, "table_type": "text", "caption": null, "header_text": "\u25cfUpon\n incorporation of Zoar Labs, one ordinary share, par value $0.001 per share, was issued to\n Mr. Kanans Visvanats."}, {"table_index": 555, "table_type": "text", "caption": null, "header_text": "Name of CompanyPlace of IncorporationAttributable Equity Interest %"}, {"table_index": 557, "table_type": "text", "caption": null, "header_text": "\u25cfadditional\n equity financing from the Company\u2019s major shareholder; and/or"}, {"table_index": 560, "table_type": "text", "caption": null, "header_text": "Property\n and Equipment"}, {"table_index": 563, "table_type": "financial", "caption": null, "header_text": "\u25cfStep\n 1: Identification of the contract, or contracts, with a customer;"}, {"table_index": 565, "table_type": "text", "caption": null, "header_text": "\u25cfControls\n the customized API before it is transferred to the customer,"}, {"table_index": 569, "table_type": "financial", "caption": null, "header_text": "Years ended March 31,"}, {"table_index": 571, "table_type": "text", "caption": null, "header_text": "As of March 31,"}, {"table_index": 573, "table_type": "text", "caption": null, "header_text": "As of March 31,"}, {"table_index": 574, "table_type": "text", "caption": null, "header_text": "As of March 31,"}, {"table_index": 575, "table_type": "text", "caption": null, "header_text": "For the years ended March 31,"}, {"table_index": 577, "table_type": "financial", "caption": null, "header_text": "March 31,"}, {"table_index": 578, "table_type": "financial", "caption": null, "header_text": "March 31,"}, {"table_index": 579, "table_type": "financial", "caption": null, "header_text": "March 31,"}, {"table_index": 581, "table_type": "financial", "caption": null, "header_text": "For the Years EndedMarch 31,"}, {"table_index": 582, "table_type": "financial", "caption": null, "header_text": "For\n the Years EndedMarch 31,"}, {"table_index": 583, "table_type": "financial", "caption": null, "header_text": "(in thousands of U.S. dollars)For\n the Years EndedMarch\n 31"}, {"table_index": 585, "table_type": "text", "caption": null, "header_text": "For\n the Years EndedMarch 31,"}, {"table_index": 586, "table_type": "financial", "caption": null, "header_text": "For\n the Years EndedMarch\n 31,"}, {"table_index": 588, "table_type": "financial", "caption": null, "header_text": "(in thousands of U.S. dollars)As of March 31,"}, {"table_index": 589, "table_type": "financial", "caption": null, "header_text": "(in thousands of U.S. dollars)As of March 31,"}, {"table_index": 591, "table_type": "text", "caption": null, "header_text": "Year Ended March 31"}, {"table_index": 593, "table_type": "financial", "caption": null, "header_text": "(in\n thousands of U.S. dollars, except share amounts and per share data)For\n the years endedMarch\n 31,"}, {"table_index": 595, "table_type": "text", "caption": null, "header_text": "(in thousands of U.S. dollars)For the years ended March 31,"}, {"table_index": 596, "table_type": "text", "caption": null, "header_text": "(in thousands of U.S. dollars)For the years ended March 31,"}, {"table_index": 597, "table_type": "text", "caption": null, "header_text": "(in thousands of U.S. dollars)As ofMarch 31,As ofMarch 31,"}, {"table_index": 600, "table_type": "financial", "caption": null, "header_text": "Page"}, {"table_index": 603, "table_type": "financial", "caption": null, "header_text": "20252024"}, {"table_index": 605, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 607, "table_type": "financial", "caption": null, "header_text": "20252024"}, {"table_index": 609, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 612, "table_type": "text", "caption": null, "header_text": "Name ofconsolidatedsubsidiaryState or otherjurisdiction ofincorporation ororganizationDate ofincorporationor formationAttributableinterest as ofDecember 31, 2025Attributableinterest as ofDecember 31, "}, {"table_index": 617, "table_type": "text", "caption": null, "header_text": "December 31, 2025"}, {"table_index": 618, "table_type": "text", "caption": null, "header_text": "December 31, 2024"}, {"table_index": 619, "table_type": "text", "caption": null, "header_text": "EstimatedDecember 31,December 31,"}, {"table_index": 621, "table_type": "financial", "caption": null, "header_text": "20252024"}, {"table_index": 622, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 623, "table_type": "text", "caption": null, "header_text": "December 31,2025December 31,2024"}, {"table_index": 626, "table_type": "financial", "caption": null, "header_text": "Income Tax Expense (Benefit)Year EndedDecember 31,2025Year EndedDecember 31,2024"}, {"table_index": 627, "table_type": "financial", "caption": null, "header_text": "Deferred Tax Assets & Liabilities:"}, {"table_index": 628, "table_type": "financial", "caption": null, "header_text": "$-$-"}, {"table_index": 631, "table_type": "financial", "caption": null, "header_text": "20252024"}, {"table_index": 633, "table_type": "financial", "caption": null, "header_text": "March 31, 2026(unaudited)December 31, 2025"}, {"table_index": 635, "table_type": "financial", "caption": null, "header_text": "20262025"}, {"table_index": 637, "table_type": "text", "caption": null, "header_text": "ShareAmountShareAmountCapitalDeficitEquitySubsidiaryTotal"}, {"table_index": 639, "table_type": "financial", "caption": null, "header_text": "20262025"}, {"table_index": 643, "table_type": "text", "caption": null, "header_text": "Name ofconsolidatedsubsidiaryState or otherjurisdiction ofincorporation ororganizationDate ofincorporationor formationAttributableinterest as ofMarch 31, 2026Attributableinterest as ofDecember 31, 202"}, {"table_index": 649, "table_type": "text", "caption": null, "header_text": "March 31, 2026December\n31, 2025"}, {"table_index": 650, "table_type": "text", "caption": null, "header_text": "March 31, 2026"}, {"table_index": 651, "table_type": "text", "caption": null, "header_text": "December 31, 2025"}, {"table_index": 652, "table_type": "financial", "caption": null, "header_text": "March\n 31, 2026December\n 31, 2025"}, {"table_index": 654, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 656, "table_type": "financial", "caption": null, "header_text": "20262025"}, {"table_index": 658, "table_type": "financial", "caption": null, "header_text": "June 30, 2026(unaudited)December 31, 2025"}, {"table_index": 660, "table_type": "financial", "caption": null, "header_text": "2026202520262025"}, {"table_index": 662, "table_type": "financial", "caption": null, "header_text": "SharesAmountSharesAmountCapitalDeficitEquitySubsidiaryTotal"}, {"table_index": 664, "table_type": "financial", "caption": null, "header_text": "20262025"}, {"table_index": 668, "table_type": "text", "caption": null, "header_text": "Name ofconsolidatedsubsidiaryState or otherjurisdiction ofincorporation ororganizationDate ofincorporationor formationAttributableinterest as ofJune 30, 2026Attributableinterest as ofDecember 31, 2025"}, {"table_index": 674, "table_type": "text", "caption": null, "header_text": "June\n30,2026December\n31,2025"}, {"table_index": 675, "table_type": "text", "caption": null, "header_text": "June 30, 2026"}, {"table_index": 676, "table_type": "text", "caption": null, "header_text": "December 31, 2025"}, {"table_index": 677, "table_type": "financial", "caption": null, "header_text": "June 30,\n 2026(unaudited)December 31, 2025"}, {"table_index": 679, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 681, "table_type": "financial", "caption": null, "header_text": "20262025"}, {"table_index": 684, "table_type": "exhibit_index", "caption": null, "header_text": "Page"}, {"table_index": 686, "table_type": "financial", "caption": null, "header_text": "5.4.Vote Required30"}, {"table_index": 688, "table_type": "financial", "caption": null, "header_text": "Section 7.REPRESENTATIONS AND WARRANTIES OF IMPACT48"}, {"table_index": 690, "table_type": "exhibit_index", "caption": null, "header_text": "Section 9.ADDITIONAL AGREEMENTS OF THE PARTIES77"}, {"table_index": 692, "table_type": "financial", "caption": null, "header_text": "Section 12.ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATION OF THE COMPANY93"}, {"table_index": 693, "table_type": "exhibit_index", "caption": null, "header_text": "Exhibit AForm of Impact Stockholder Voting and Support Agreement"}, {"table_index": 712, "table_type": "text", "caption": null, "header_text": "TermSection"}, {"table_index": 714, "table_type": "text", "caption": null, "header_text": "TermSection"}, {"table_index": 716, "table_type": "text", "caption": null, "header_text": "TermSection"}, {"table_index": 718, "table_type": "exhibit_index", "caption": null, "header_text": "TermSection"}, {"table_index": 720, "table_type": "text", "caption": null, "header_text": "TermSection"}, {"table_index": 798, "table_type": "text", "caption": null, "header_text": "If\n to Impact, to:c/o\n Impact BioMedical Inc275 Wiregrass PkwyHenrietta, NY 14586.Attention:Frank D. HeuszelEmail:frank.heuszel@impactbiomedinc.comwith\n a copy (which will not constitute notice) to:Si"}, {"table_index": 801, "table_type": "text", "caption": null, "header_text": "Dr AshleyS Limited"}, {"table_index": 803, "table_type": "text", "caption": null, "header_text": "IMPACT BIOMEDICAL INC."}, {"table_index": 805, "table_type": "text", "caption": null, "header_text": "DR ASHLEYS NEVADA SUB, INC."}, {"table_index": 807, "table_type": "text", "caption": null, "header_text": "DR ASHLEYS BIO LABS LIMITED"}, {"table_index": 809, "table_type": "text", "caption": null, "header_text": "Dr\n Ashleys Shareholder"}, {"table_index": 824, "table_type": "text", "caption": null, "header_text": "ZOAR\n Limited"}, {"table_index": 826, "table_type": "text", "caption": null, "header_text": "ZOAR\n LABS LImited"}, {"table_index": 828, "table_type": "text", "caption": null, "header_text": "DR\n ASHLEYS NEVADA SUB, INC."}, {"table_index": 830, "table_type": "text", "caption": null, "header_text": "Dr.\n Ashley SHAREHOLDER"}, {"table_index": 856, "table_type": "text", "caption": null, "header_text": "NameCommon SharesCommon Shares convertible from the Impact Series A Preferred Stock (on a 1:1 basis)Common\n Stock Convertible from the Promissory Note (Conversion rate of $0.50 per share as on date of"}, {"table_index": 858, "table_type": "text", "caption": null, "header_text": "IMPACT BIOMEDICAL INC."}, {"table_index": 860, "table_type": "text", "caption": null, "header_text": "Dr. Ashley Limited"}, {"table_index": 862, "table_type": "text", "caption": null, "header_text": "Dr Ashley Bio LABS LImited"}, {"table_index": 864, "table_type": "text", "caption": null, "header_text": "DR. ASHLEYS NEVADA SUB, INC."}, {"table_index": 866, "table_type": "text", "caption": null, "header_text": "Dr.\n Ashley STOCKHOLDER"}, {"table_index": 868, "table_type": "text", "caption": null, "header_text": "DSS, INC.:"}, {"table_index": 870, "table_type": "text", "caption": null, "header_text": "DSS BIOHEALTH SECURITY, INC.:"}, {"table_index": 872, "table_type": "text", "caption": null, "header_text": "DSS PUREAIR, INC.:"}, {"table_index": 875, "table_type": "text", "caption": null, "header_text": "NameCommon Shares"}, {"table_index": 881, "table_type": "text", "caption": null, "header_text": "If\n to Impact or Frank D. Heuszel:with\n a copy (which will not constitute notice) to:"}, {"table_index": 882, "table_type": "text", "caption": null, "header_text": "If to PubCo,\n to:with a copy\n (which will not constitute notice) to:"}, {"table_index": 883, "table_type": "text", "caption": null, "header_text": "If\n to Dr Ashleys Shareholder, to:with a copy\n (which will not constitute notice) to:"}, {"table_index": 884, "table_type": "text", "caption": null, "header_text": "If to DSS,\n to:with a copy\n (which will not constitute notice) to:"}, {"table_index": 887, "table_type": "text", "caption": null, "header_text": "Dr AshleyS Limited"}, {"table_index": 889, "table_type": "text", "caption": null, "header_text": "Impact BioMedical Inc."}, {"table_index": 891, "table_type": "text", "caption": null, "header_text": "fRANK\n D. HEUSZEL"}, {"table_index": 893, "table_type": "text", "caption": null, "header_text": "DSS, INC."}, {"table_index": 899, "table_type": "text", "caption": null, "header_text": "ZOAR\n Limited"}, {"table_index": 903, "table_type": "text", "caption": null, "header_text": "fRANK\n D. HEUSZEL"}, {"table_index": 905, "table_type": "text", "caption": null, "header_text": "DSS,\n INC."}, {"table_index": 918, "table_type": "text", "caption": null, "header_text": "\u201cAffiliate\u201dmeans\n in respect of a Person, any other Person that, directly or indirectly, through one or more intermediaries, controls, is controlled\n by, or is under common control with, such Person, "}, {"table_index": 920, "table_type": "text", "caption": null, "header_text": "\u201cClass\u201d\n or \u201cClasses\u201dmeans\n any class or classes of Shares as may from time to time be issued by the Company;"}, {"table_index": 922, "table_type": "text", "caption": null, "header_text": "\u201cOrdinary\n Resolution\u201dmeans\n a resolution:"}, {"table_index": 923, "table_type": "text", "caption": null, "header_text": "\u201cOrdinary\n Share\u201dmeans\n an ordinary share of a par value of US$0.0001 in the capital of the Company, designated as an Ordinary Share and having the rights\n provided for in these Articles;"}, {"table_index": 925, "table_type": "text", "caption": null, "header_text": "\u201cShare\u201dmeans\n a share in the capital of the Company. All references to \u201cShares\u201d herein shall be deemed to be Shares of any or all Classes\n as the context may require. For the avoidance of doubt in the"}, {"table_index": 926, "table_type": "text", "caption": null, "header_text": "(a)passed\n by not less than two-thirds of the votes cast by such Shareholders as, being entitled to\n do so, vote in person or, where proxies are allowed, by proxy or, in the case of corporations,\n by "}, {"table_index": 927, "table_type": "text", "caption": null, "header_text": "\u201cTreasury\n Share\u201dmeans\n a Share held in the name of the Company as a treasury share in accordance with the Companies Act;"}, {"table_index": 1032, "table_type": "text", "caption": null, "header_text": "56.All\n general meetings other than annual general meetings shall be called extraordinary general\n meetings."}, {"table_index": 1036, "table_type": "exhibit_index", "caption": null, "header_text": "(a)The\n Chairman or a majority of the Directors (acting by a resolution of the Board) may call general\n meetings, and they shall on a Shareholders\u2019 requisition forthwith proceed to convene\n an extraor"}, {"table_index": 1038, "table_type": "text", "caption": null, "header_text": "(a)in\n the case of an annual general meeting, by all the Shareholders (or their proxies) entitled\n to attend and vote thereat; and"}, {"table_index": 1041, "table_type": "text", "caption": null, "header_text": "61.No\n business except for the appointment of a chairman for the meeting shall be transacted at\n any general meeting unless a quorum of Shareholders is Present at the time when the meeting\n proceeds t"}, {"table_index": 1042, "table_type": "text", "caption": null, "header_text": "(a)The\n chairman of the meeting shall be deemed to be Present at the meeting; and"}, {"table_index": 1044, "table_type": "text", "caption": null, "header_text": "66.The\n chairman of any general meeting at which a quorum is Present may with the consent of the\n meeting (and shall if so directed by the meeting) adjourn the meeting from time to time and\n from plac"}, {"table_index": 1045, "table_type": "text", "caption": null, "header_text": "71.Subject\n to any rights and restrictions for the time being attached to any Share on a poll every Shareholder\n Present in person or represented by its duly authorised representative or proxy shall h"}, {"table_index": 1047, "table_type": "text", "caption": null, "header_text": "77.An\n instrument appointing a proxy may be in any usual or common form or such other form as the\n Directors may approve."}, {"table_index": 1052, "table_type": "text", "caption": null, "header_text": "(a)Unless\n otherwise determined by the Company in general meeting, the number of Directors shall not\n be less than three (3) Directors, the exact number of Directors to be determined\n from time to tim"}, {"table_index": 1053, "table_type": "financial", "caption": null, "header_text": "84.A\n Director may be removed from office by an Ordinary Resolution, notwithstanding anything\n in these Articles or in any agreement between the Company and such Director (but without\n prejudice to an"}, {"table_index": 1055, "table_type": "text", "caption": null, "header_text": "89.Any\n Director may in writing appoint another Person to be his alternate and, save to the extent\n provided otherwise in the form of appointment, such alternate shall have authority to sign\n written "}, {"table_index": 1056, "table_type": "financial", "caption": null, "header_text": "91.Subject\n to the Companies Act, these Articles and any resolutions passed in a general meeting, the\n business of the Company shall be managed by the Directors, who may pay all expenses incurred\n in "}, {"table_index": 1058, "table_type": "text", "caption": null, "header_text": "93.The\n Directors may appoint any natural person or corporation to be a Secretary (and if need be\n an assistant Secretary or assistant Secretaries) who shall hold office for such term, at\n such remune"}, {"table_index": 1061, "table_type": "text", "caption": null, "header_text": "101.The\n Seal shall not be affixed to any instrument except by the authority of a resolution of the\n Directors provided always that such authority may be given prior to or after the affixing\n of the S"}, {"table_index": 1063, "table_type": "text", "caption": null, "header_text": "(a)becomes\n bankrupt or makes any arrangement or composition with his creditors;"}, {"table_index": 1065, "table_type": "text", "caption": null, "header_text": "105.The\n Directors may meet together (either within or outside the Cayman Islands) for the dispatch\n of business, adjourn, and otherwise regulate their meetings and proceedings as they think\n fit. Que"}, {"table_index": 1068, "table_type": "text", "caption": null, "header_text": "(a)all\n appointments of officers made by the Directors;"}, {"table_index": 1069, "table_type": "exhibit_index", "caption": null, "header_text": "112.When\n the chairman of a meeting of the Directors signs the minutes of such meeting the same shall\n be deemed to have been duly held notwithstanding that all the Directors have not actually\n come t"}, {"table_index": 1072, "table_type": "financial", "caption": null, "header_text": "119.Subject\n to any rights and restrictions for the time being attached to any Shares, the Directors may\n from time to time declare dividends (including interim dividends) and other distributions\n on "}, {"table_index": 1074, "table_type": "exhibit_index", "caption": null, "header_text": "128.The\n books of account relating to the Company\u2019s affairs shall be kept in such manner as\n may be determined from time to time by the Directors."}, {"table_index": 1079, "table_type": "text", "caption": null, "header_text": "(i)paying\n up the amounts (if any) for the time being unpaid on Shares held by them respectively, or"}, {"table_index": 1080, "table_type": "text", "caption": null, "header_text": "(c)make\n any arrangements they think fit to resolve a difficulty arising in the distribution of a\n capitalised reserve and in particular, without limitation, where Shares or debentures become\n distrib"}, {"table_index": 1081, "table_type": "text", "caption": null, "header_text": "(i)the\n allotment to the Shareholders respectively, credited as fully paid, of Shares or debentures\n to which they may be entitled on the capitalisation, or"}, {"table_index": 1084, "table_type": "text", "caption": null, "header_text": "(a)employees\n (including Directors) or service providers of the Company or its Affiliates upon exercise\n or vesting of any options or awards granted under any share incentive scheme or employee\n benef"}, {"table_index": 1086, "table_type": "text", "caption": null, "header_text": "138.The\n Directors shall in accordance with the Companies Act establish a Share Premium Account and\n shall carry to the credit of such account from time to time a sum equal to the amount or\n value of "}, {"table_index": 1087, "table_type": "exhibit_index", "caption": null, "header_text": "140.Except\n as otherwise provided in these Articles, any notice or document may be served by the Company\n or by the Person entitled to give notice to any Shareholder either personally, or by posting\n "}, {"table_index": 1088, "table_type": "text", "caption": null, "header_text": "(a)post,\n shall be deemed to have been served five calendar days after the time when the letter containing\n the same is posted;"}, {"table_index": 1090, "table_type": "exhibit_index", "caption": null, "header_text": "144.Any\n notice or document delivered or sent by post to or left at the registered address of any\n Shareholder in accordance with the terms of these Articles shall notwithstanding that such\n Sharehold"}, {"table_index": 1091, "table_type": "text", "caption": null, "header_text": "(a)all\n Shareholders holding Shares with the right to receive notice and who have supplied to the\n Company an address for the giving of notices to them; and"}, {"table_index": 1092, "table_type": "text", "caption": null, "header_text": "146.Subject\n to the relevant laws, rules and regulations applicable to the Company, no Shareholder shall\n be entitled to require discovery of any information in respect of any detail of the Company\u2019s\n"}, {"table_index": 1094, "table_type": "financial", "caption": null, "header_text": "148.Every\n Director (including for the purposes of this Article any alternate Director appointed pursuant\n to the provisions of these Articles), Secretary, assistant Secretary, or other officer for\n t"}, {"table_index": 1095, "table_type": "text", "caption": null, "header_text": "(a)for\n the acts, receipts, neglects, defaults or omissions of any other Director or officer or agent\n of the Company; or"}, {"table_index": 1099, "table_type": "financial", "caption": null, "header_text": "152.If\n the Company shall be wound up the liquidator may, with the sanction of a Special Resolution\n of the Company and any other sanction required by the Companies Act, divide amongst the Shareholder"}, {"table_index": 1101, "table_type": "text", "caption": null, "header_text": "155.For\n the purpose of determining those Shareholders that are entitled to receive notice of, attend\n or vote at any meeting of Shareholders or any adjournment thereof, or those Shareholders\n that ar"}, {"table_index": 1115, "table_type": "financial", "caption": null, "header_text": "3.Dividends.\n Dividends may be declared and paid on the Common Stock from funds lawfully available therefor as and when determined by the Board\n of Directors and subject to the requirements of applica"}, {"table_index": 1118, "table_type": "text", "caption": null, "header_text": "By:"}], "exhibits_pending": false, "cdn_html": true, "response_time_ms": 37}